On November 30, 2016, the Board of Directors of Intersections
Inc. (the “Company”) approved the closure of the Company’s Pet
Health Monitoring segment, known as Voyce, effective immediately.
As a result of the closure, the Company currently estimates that
it will incur cash costs related to the shutdown of between $2.0
and $2.5 million, a substantial portion of which will be
severance and employee-related costs. The Company expects these
costs to be paid over the next six months. In addition, the
Company currently expects to record a pre-tax non-cash impairment
charge, for long-lived asset impairments including inventory and
fixed assets, up to $7.7 million in the fourth quarter of 2016.
This non-cash impairment charge will not impact the Company’s
future cash flow, liquidity, compliance with its debt covenants
or any future operations, and will not result in any future cash
expenditures.

The Company may incur additional costs or charges related to the
actions described above. Although the Company cannot currently
predict the amount or timing of these other charges at this time,
these additional costs or charges could be material. To the
extent required by applicable rules of the Securities and
Exchange Commission (the “SEC”), in the event the Company
determines that it will have additional costs or charges
associated with the shutdown, it will file one or more amendments
to this Current Report on Form 8-K and/or include such
disclosures in future Quarterly Reports on Form 10-Q or its
Annual Report on Form 10-K.

Forward-Looking Statements:

Statements in this report relating to future plans, results,
performance, expectations, achievements and the like, including
estimates or projections of future costs and cash expenditures of
shutting down the Company’s Pet Health Monitoring business, are
considered “forward-looking statements” under the Private
Securities Litigation Reform Act of 1995. You can identify
forward-looking statements by the fact that they do not relate
strictly to historical or current facts. These statements may
include words such as “anticipate,” “estimate,” “expect,”
“project,” “plan,” “intend,” “believe,” “may,”
“should,” “can have,” “likely” and other words and terms of
similar meaning in connection with any discussion of the timing
or nature of future operating or financial performance or other
events. Those forward-looking statements involve known and
unknown risks and uncertainties and are subject to change based
on various factors and uncertainties that may cause actual
results to differ materially from those expressed or implied by
those statements, including the impact of shutting down our Pet
Health Monitoring segment; whether we will incur additional costs
or charges relating to the shutdown; whether we will reach
definitive agreement with our lender on mutually agreeable terms,
or at all, and its impact on our outstanding debt; the timing and
success of new product launches and other growth initiatives; the
continuing impact of the regulatory environment on our business;
the continued dependence on a small number of financial
institutions for a majority of our revenue and to service our
U.S. financial institution customer base; our ability to execute
our strategy and previously announced transformation plan; our
incurring additional restructuring charges; our incurring
additional impairment costs or charges on goodwill and/or assets;
our ability to control costs; and our needs for additional
capital to grow our business, including our ability to maintain
compliance with the covenants under our new term loan or seek
additional sources of debt and/or equity financing. Factors and
uncertainties that may cause actual results to differ include but
are not limited to the risks disclosed under “Forward-Looking
Statements,” “Item 1. BusinessGovernment Regulation” and
“Item 1A. Risk Factors” in the Company’s most recent Annual
Report on Form 10-K and Quarterly Reports on Form 10-Q and in its
recent other filings with the U.S. Securities and Exchange
Commission. The Company undertakes no obligation to revise or
update any forward-looking statements unless required by
applicable law.

Item 2.06. Material Impairments.

The information required to be disclosed under this item is
included in Item 2.05 above and incorporated by reference into
this Item 2.06.

Item 7.01. Regulation FD Disclosure.

On December 1, 2016, the Company issued a press release
announcing the closure of its Pet Health Monitoring business to
concentrate resources on identity and privacy protection service
opportunities, a copy of which is being furnished as an exhibit
to this Current Report on Form 8-K and is incorporated by
reference into this Item 7.01.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits